Stocklytics Platform
Asset logo for symbol SANA
Sana Biotechnology
SANA51
$2.84arrow_drop_down1.73%-$0.05
Penny Stock
Asset logo for symbol SANA
SANA51

$2.84

arrow_drop_down1.73%

Performance History

Chart placeholder
Key Stats
Open$2.89
Prev. Close$2.89
EPS-1.40
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$642.92M
PE Ratio-
LOWHIGH
Day Range2.88
2.89
52 Week Range2.74
12.00
Ratios
Revenue-
EBITDA Margin %-
EPS-1.40

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Sana Biotechnology (SANA)

Sana Biotechnology, Inc. (SANA) is a leading biotechnology company focused on creating and delivering engineered cells as medicines. With a strong emphasis on cellular engineering and regenerative medicine, Sana is at the forefront of developing breakthrough therapies to treat a wide range of diseases and conditions. The company's mission is to harness the power of cells to transform healthcare and improve the lives of patients worldwide.
SANA stock has shown a steady growth trajectory since its inception. With a current market cap of billions of dollars, SANA has become one of the most prominent players in the biotechnology industry. The company's stock price history reflects this success, with consistent upward movement in recent years.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Steven D. Harr M.D.
Headquarters
Seattle
Employees
424
Exchange
NASDAQ
add Sana Biotechnology to watchlist

Keep an eye on Sana Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Sana Biotechnology's (SANA) price per share?

The current price per share for Sana Biotechnology (SANA) is $2.84. The stock has seen a price change of -$0.05 recently, indicating a -1.73% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Sana Biotechnology (SANA)?

For Sana Biotechnology (SANA), the 52-week high is $12, which is 322.54% from the current price. The 52-week low is $2.74, the current price is 3.46% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Sana Biotechnology (SANA) a growth stock?

Sana Biotechnology (SANA) has shown an average price growth of -3.67% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Sana Biotechnology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Sana Biotechnology (SANA) stock price performance year to date (YTD)?

As of the latest data, Sana Biotechnology (SANA) has a year-to-date price change of -32.38%. Over the past month, the stock has experienced a price change of -29.18%. Over the last three months, the change has been -41.92%. Over the past six months, the figure is -64.1%.
help

Is Sana Biotechnology (SANA) a profitable company?

Sana Biotechnology (SANA) has a net income of -$283.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$326.9M. Furthermore, the EBITDA is -$273.8M.
help

What is the market capitalization of Sana Biotechnology (SANA)?

Sana Biotechnology (SANA) has a market capitalization of $631.8M. The average daily trading volume is 2.8, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level